Keyphrases
PET-MRI
92%
Positron Emission Tomography
52%
18F-fluorodeoxyglucose (18F-FDG)
39%
13C Pyruvate
37%
HyperPET
37%
Headache
34%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
28%
Functional Magnetic Resonance Imaging
28%
Healthy Volunteers
28%
Dilatation
28%
Positron Emission Tomography-computed Tomography (PET-CT)
27%
Magnetic Resonance Imaging
26%
In Cancer
25%
Blood Oxygenation Level-dependent Response
24%
Middle Meningeal Artery
24%
Magnetic Resonance Spectroscopy
24%
Tumor Recurrence
24%
Cancer Patients
24%
Simultaneous PET-MR
24%
Lactate
24%
Middle Cerebral Artery
23%
Sumatriptan
22%
FDG Uptake
21%
Fluorodeoxyglucose
21%
Arterial Spin Labeling
20%
Phase Contrast
19%
FDG Positron Emission Tomography
19%
Migraine
18%
Cerebral Blood Flow
18%
Histology
17%
T1-weighted
17%
Glycolysis
16%
Magnetic Resonance Angiography
16%
Carotid Artery
16%
F-18
16%
Migraine without Aura (MWoA)
16%
Clinical PET
16%
Contrast-enhancing Lesions
15%
Medicine and Dentistry
Polyethylene Terephthalate
100%
Magnetic Resonance Imaging
63%
positron emission tomographic scan
48%
Malignant Neoplasm
41%
Pyruvic Acid
37%
Carbon 13
35%
Fluorodeoxyglucose F 18
34%
Fluorine-18
27%
Migraine
26%
Brain Imaging
24%
NMR Spectroscopy
24%
Tumor Recurrence
24%
Lactic Acid
20%
Headache
20%
Atherosclerosis
19%
Magnetic Resonance Imaging
17%
Gene Expression
16%
Migraine without Aura
15%